MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.
about
Novel non invasive diagnostic strategies in bladder cancerClinicopathologic and prognostic significance of p21 (Cip1/Waf1) expression in bladder cancer.Murine Double Minute 2 SNP T309G Polymorphism and Urinary Tract Cancer Risk: A Meta-AnalysisMeta-analysis of associations between MDM2 SNP309 polymorphism and gastric cancer risk.Expression of MDM2 mRNA, MDM2, P53 and P16 Proteins in Urothelial Lesions in the View of the WHO 4th Edition Guidelines as a Molecular Insight towards Personalized Medicine.P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma.Investigation of the association between the MDM2 T309G polymorphism and gastric cancer.Association of p53 and mdm2 in the development and progression of non-small cell lung cancer.
P2860
Q26752188-AFFA95CD-D8D9-4AF2-8CD7-7EE4DE8A8AB0Q35854027-E8970FED-8F24-4EC3-BA2E-D5445225F860Q37205283-C23358A0-1613-45F5-9D27-4030F7BEC636Q37565358-F5849322-C580-4CF2-8FE8-FE72D3AB35F5Q41465239-734AE724-3F60-4D67-BC09-58794E86AC59Q44176695-DE8C678A-3CD1-47E6-A637-02DF6BB0EFC8Q44416876-541C3F09-6256-4210-98B3-AB12A9815CBFQ47157603-81B332E9-B88B-4580-BC74-5725E1C20E86Q53620032-2E4C2966-154A-4734-B25D-C8C8720D5B98
P2860
MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@ast
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@en
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@nl
type
label
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@ast
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@en
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@nl
prefLabel
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@ast
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@en
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@nl
P2093
P2860
P356
P1433
P1476
MDM2 SNP309 promoter polymorph ...... ry bladder carcinoma stage T1.
@en
P2093
Hans Olsson
Johan Rosell
Per Hultman
Peter Söderkvist
Staffan Jahnson
P2860
P2888
P356
10.1186/1471-2490-13-5
P577
2013-01-28T00:00:00Z
P5875
P6179
1014636117